Pierfranco Conte, MD, discusses findings and implications of the A-BRAVE study.
Pierfranco Conte, MD
Advertisement
Pierfranco Conte, MD, is the scientific director of the San Camillo IRCCS Hospital in Venice Lido, Italy.
Articles by Pierfranco Conte, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
